Heart muscle disease registry for non-ischemic conditions
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial is a registry, meaning it collects health information to help doctors study heart muscle diseases and plan future cardiovascular studies. You may be able to join if you have a non-ischemic cardiomyopathy such as dilated cardiomyopathy, certain forms of thick heart muscle, non-compaction, or arrhythmogenic right-sided disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a non-ischemic heart muscle disease (not caused by blocked heart arteries).
- You are between 18 and 80 years old.
- You can understand the study consent form and sign it.
- Your specific diagnosis fits one of the registry categories the study is tracking (based on the site’s TORCH-Plus rules).
- You do not have major conditions that would block participation (like severe heart valve disease or certain lung/heart pressure disorders).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study collects information, blood samples, and MRI images from people with non-ischemic cardiomyopathy (a heart muscle disease not caused by blocked arteries). By joining, you help researchers better understand the condition and find new ways to diagnose and treat it.
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
This study builds a patient registry to collect information over time about several types of cardiomyopathy (heart muscle diseases). It may help researchers understand how these conditions progress and what care works best.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
This study collects information from heart MRIs of people with hypertrophic cardiomyopathy, a condition where the heart muscle is unusually thick. The registry looks at how a special dye (gadolinium) highlights scarring in the heart, which may help doctors better understand and treat this condition.
This registry collects information from people with a specific heart condition called arrhythmogenic cardiomyopathy who have an ICD (a device that helps control heart rhythm). The goal is to learn more about heart rhythm problems and how the ICD responds.
Hear when a new Non-ischemic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.